Publication | Open Access
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two‐year outcomes after the study closure
69
Citations
16
References
2020
Year
Study ClosureThrombosisVenous ThrombosisTwo‐year OutcomesCardiovascular DiseaseMedicineCardiovascular PharmacologyPharmacotherapyAntiphospholipid SyndromePharmacologyAnticoagulantCardiology
| Year | Citations | |
|---|---|---|
Page 1
Page 1